DR CORPORATION LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.13 CNY | +0.95% |
|
+2.63% | -35.13% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 50,913 | 25,193 | 11,796 | 7,652 | - | - |
| Enterprise Value (EV) 1 | 50,913 | 25,193 | 11,796 | 7,652 | 7,652 | 7,652 |
| P/E ratio | 35.2 x | 34.6 x | 173 x | 29.4 x | 22.5 x | 12.4 x |
| Yield | 1.57% | 1.59% | 1.7% | 1.62% | 2.3% | - |
| Capitalization / Revenue | 11 x | 6.84 x | 5.41 x | 3.62 x | 3.28 x | 1.99 x |
| EV / Revenue | 11 x | 6.84 x | 5.41 x | 3.62 x | 3.28 x | 1.99 x |
| EV / EBITDA | 30.1 x | 18.5 x | 52.8 x | 17.9 x | 17.1 x | 9.26 x |
| EV / FCF | - | 3,80,05,532 x | - | - | - | - |
| FCF Yield | - | 0% | - | - | - | - |
| Price to Book | 7.41 x | 3.7 x | 1.82 x | 1.21 x | 1.21 x | 1.24 x |
| Nbr of stocks (in thousands) | 4,00,010 | 4,00,010 | 4,00,010 | 4,00,010 | - | - |
| Reference price 2 | 127.3 | 62.98 | 29.49 | 19.13 | 19.13 | 19.13 |
| Announcement Date | 28/02/22 | 27/04/23 | 26/04/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 4,623 | 3,682 | 2,180 | 2,112 | 2,331 | 3,848 |
| EBITDA 1 | - | 1,694 | 1,361 | 223.3 | 426.6 | 446.7 | 826.7 |
| EBIT 1 | - | 1,633 | 884.9 | 117.7 | 321.4 | 417.6 | 753.8 |
| Operating Margin | - | 35.31% | 24.04% | 5.4% | 15.22% | 17.91% | 19.59% |
| Earnings before Tax (EBT) 1 | - | 1,632 | 885.4 | 112.8 | 318.9 | 415.1 | 749 |
| Net income 1 | 563.3 | 1,302 | 729.2 | 68.96 | 260.2 | 338 | 614.2 |
| Net margin | - | 28.16% | 19.81% | 3.16% | 12.32% | 14.5% | 15.96% |
| EPS 2 | 1.560 | 3.620 | 1.820 | 0.1700 | 0.6500 | 0.8500 | 1.540 |
| Free Cash Flow | - | - | 662.9 | - | - | - | - |
| FCF margin | - | - | 18% | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | 48.69% | - | - | - | - |
| FCF Conversion (Net income) | - | - | 90.9% | - | - | - | - |
| Dividend per Share 2 | - | 2.000 | 1.000 | 0.5000 | 0.3100 | 0.4400 | - |
| Announcement Date | 27/04/21 | 28/02/22 | 27/04/23 | 26/04/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | 663 | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 32.6% | 10.7% | 1.04% | 4.1% | 5.39% | 9.94% |
| ROA (Net income/ Total Assets) | - | 25.5% | 8.54% | 0.84% | 1.7% | 2.4% | - |
| Assets 1 | - | 5,100 | 8,542 | 8,173 | 15,304 | 14,085 | - |
| Book Value Per Share 2 | - | 17.20 | 17.00 | 16.20 | 15.80 | 15.80 | 15.50 |
| Cash Flow per Share 2 | - | 3.860 | 2.050 | 0.0900 | 0.2800 | 0.6100 | 0.3400 |
| Capex 1 | - | 103 | 155 | 77.1 | 1.82 | 18.5 | 2.68 |
| Capex / Sales | - | 2.23% | 4.21% | 3.54% | 0.09% | 0.79% | 0.07% |
| Announcement Date | 27/04/21 | 28/02/22 | 27/04/23 | 26/04/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
19.13
CNY
Average target price
23.36
CNY
Spread / Average Target
+22.11%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -35.13% | 104.25Cr | |
| +21.73% | 9.22TCr | |
| -8.57% | 3.62TCr | |
| +6.88% | 1.16TCr | |
| -28.66% | 1.04TCr | |
| -13.80% | 337.8Cr | |
| -3.14% | 222.27Cr | |
| -13.18% | 196.9Cr | |
| 0.00% | 162.6Cr | |
| -15.31% | 135.42Cr |
- Stock Market
- Equities
- 301177 Stock
- Financials DR Corporation Limited
